In line with our previous findings that STS patients might have compromised NK activity due to the decrease in the frequency of the circulating most effector subset CD56dim NK cells and the decrease in the expression of PRF1, GZMB, and KLRK1 [12], we performed a more detailed characterization of NK cytotoxic activity and receptor repertoire. The gene discussed is PRF1; the disease is telomere syndrome.